Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826423 · ClinicalTrials.gov registry record
Mycobacterium Avium Intracellulare Complex (MAC) Study
A clinical trial of Mycobacterium Avium Intracellulare Complex (MAC), sponsored by Mayo Clinic.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00826423 is a study of Mycobacterium Avium Intracellulare Complex (MAC) that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00826423, a study of Mycobacterium Avium Intracellulare Complex (MAC), has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is short course (3 month) multiple drug antibiotic therapy. The purpose of this research study is to evaluate the clinical and radiology response to assess whether drug resistance develops and assess quality of life measures with MAC disease.
Conditions Studied
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826423
The ClinicalTrials.gov registry entry for NCT00826423 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mycobacterium Avium Intracellulare Complex (MAC) appearing as the primary indexed condition, and to 0 interventions.
NCT00826423 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00826423 about?
NCT00826423 is a clinical study titled "Mycobacterium Avium Intracellulare Complex (MAC) Study". This study is short course (3 month) multiple drug antibiotic therapy. The purpose of this research study is to evaluate the clinical and radiology response to assess whether drug resistance develops and assess quality of life measures with MAC disease.
What is the current status of trial NCT00826423?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2008-06. Estimated completion is 2011-09.
What conditions does trial NCT00826423 study?
This clinical trial studies the following conditions: Mycobacterium Avium Intracellulare Complex (MAC).
Who is sponsoring clinical trial NCT00826423?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00826423 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.